Sulfadiazine
- Generic Name
- Sulfadiazine
- Drug Type
- Small Molecule
- Chemical Formula
- C10H10N4O2S
- CAS Number
- 68-35-9
- Unique Ingredient Identifier
- 0N7609K889
Overview
One of the short-acting sulfonamides used in combination with pyrimethamine to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
Background
One of the short-acting sulfonamides used in combination with pyrimethamine to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
Indication
For the treatment of rheumatic fever and meningococcal meningitis
Associated Conditions
- Acute Otitis Media caused by Haemophilus Influenzae
- Chancroid
- Conjunctivitis, Inclusion
- Encephalitis
- Malaria caused by Plasmodium falciparum
- Meningitis caused by Haemophilus influenzae
- Meningococcal Meningitis
- Nocardiosis
- Trachoma
- Urinary Tract Infection
- Wound Infections
- Recurrent Rheumatic fever
Clinical Trials
FDA Approved Products
Sulfadiazine
Manufacturer:Eon Labs, Inc.
Route:ORAL
Strength:500 mg in 1 1
Approved: 2020/06/30
NDC:0185-0757
SULFADIAZINE
Manufacturer:EPIC PHARMA, LLC
Route:ORAL
Strength:500 mg in 1 1
Approved: 2021/12/15
NDC:42806-757
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath